Clinical Trial: TTVR STRONG Under Coverage With Evidence Development (CED) Study

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06833476) titled 'TTVR STRONG Under Coverage With Evidence Development (CED) Study' on Feb. 13.

Brief Summary: This Coverage with Evidence Development (CED) study measures the long-term health outcomes of patients with severe, symptomatic Tricuspid Regurgitation who received a Transcatheter Tricuspid Valve Replacement procedure using the EVOQUE system.

Study Start Date: March 19

Study Type: OBSERVATIONAL

Condition: Tricuspid Regurgitation

Intervention: OTHER: EVOQUE

This is a retrospective, non-randomized study. The decision to intervene by TTVR with the EVOQUE device is made by the heart team.

Recruitment Status: RECRUITING

Sponsor: Edwards...